High levels of lymphoid expression of enhanced green fluorescent protein in nonhuman primates transplanted with cytokine-mobilized peripheral blood CD34+ cells

Blood

Volumn 95, Issue 2, 2000, Pages 445-452

  Donahue, Robert E ^a   Wersto, Robert P ^b   Allay, James A ^b   Agricola, Brian A ^b   Metzger, Mark E ^b   Nienhuis, Arthur W ^b   Persons, Derek A ^b   Sorrentino, Brian P ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD20 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DIHYDROFOLATE REDUCTASE; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; MACACA; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0034650942     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.2.445     Document Type: Article

References (38)

1. Sorrentino BP, Nienhuis AW. The hematopoietic system as a target for gene therapy. In: Friedmann T, ed. The Development of Human Gene Therapy: Monograph 36. New York, NY: Cold Spring Harbor Laboratory Press; 1999:351-426.
2. Persons DA, Allay JA, Allay ER, et al. Retroviral-mediated transfer of the green fluorescent protein gene Into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood. 1997;90:1777-1786.
3. van Beusechem VW, Kukler A, Heidt PJ, Valerio D. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc Natl Acad Sci U S A. 1992;89:7640-7644.
4. + bone marrow cells. Blood. 1993;82:1975-1980.
5. + hematopoietic cell transduction with cell-free retroviral vector preparations. Proc Natl Acad Sci U S A. 1995;92:4372-4376.
6. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood. 1995;85:3048-3057.
7. Dunbar CE, Seidel NE, Doren S, et al. Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc Natl Acad Sci U S A. 1996;93:11,871-11,876.
8. Kiem HP, Andrews RG, Morris J, et al. Improved gene transfer into baboon marrow repopulaling cells using recombinant human fibronectin fragment CH-296 In combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood. 1998;92: 1878-1886.
9. Tisdale JF, Hanazono Y, Sellers SE, et al. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood. 1998;92: 1131-1141.
10. Kiem HP, Heyward S, Winkler A, et al. Gene transfer into marrow repopulating cells: comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood. 1997;90:4638-4645.
11. Challita PM, Kohn DB. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci U S A. 1994;91: 2567-2571.
12. Challita PM, Skelton D, el-Khoueiry A, Yu XJ, Weinberg K, Kohn DB. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J Virol. 1995;69:748-755.
13. Hawley RG, Fong AZ, Burns BF, Hawley TS. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med. 1992;176:1149-1163.
14. Pawliuk R, Eaves CJ, Humphries RK. Sustained high-level reconstitution of the hematopoietic system by preselected hematopoietic cells expressing a transduced cell-surface antigen. Hum Gene Ther. 1997;8:1595-1604.
15. Miyoshi H, Takahashi M, Gage FH, Verma IM. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci U S A. 1997;94:10,319-10,323.
16. Kafri T, Blomer U, Peterson DA, Gage FH, Verma IM. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet. 1997;17:314-317.
17. Persons DA, Allay JA, Riberdy JM, et al. Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells. Nat Med. 1998;4:1201-1205.
18. Allay JA, Persons DA, Galipeau J, et al. In vivo selection of retrovirally transduced hematopoietic stem cells. Nat Med. 1998;4:1136-1143.
19. + cells in Thy-1 expression and cell cycle status in non-human primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood. 1996;87:1644-1653.
20. Spencer HT, Sleep SE, Rehg JE, Blakley RL, Sorrentino BP. A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood. 1996;87:2579-2587.
21. Huang ZM, Yen TS. Hole of the hepatitis B virus post transcriptional regulatory element in export of intronless transcripts. Mol Cell Biol. 1995;15: 3864-3869.
22. Bodine DM, Seidel NE, Gale MS, Nienhuis AW, Ortic D. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem call factor. Blood. 1994;84:1482-1491.
23. Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams DA. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med. 1996;2:876-882.
24. Yokota T, Oritani K, Mitsui H, et al. Growth-supporting activities of fibronectin on hematopoietic stem/progenitor cells in vitro and in vivo: structural requirement for fibronectin activities of CS1 and cell-binding domains. Blood. 1998;91:3263-3272.
25. + progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transductton. Blood. 1997;89:446-456.
26. Zandstra PW, Conneally E, Petzer AL, Piret M, Eaves CJ. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci U S A. 1997;94:4698-4703.
27. Bhatia M, Bonnet D, Kapp U, Wang JC, Murdoch B, Dick JE. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med. 1997; 186:619-624.
28. + cells. Blood. 1996;88:4166-4172.
29. Bhatia M, Bonnet C, Murdoch B, San OI, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 1998;4:1038-1045.
30. Conneally E, Eaves CJ, Humphries RK. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood. 1998;91:3487-3493.
31. Schilz AJ, Brouns G, Knoss H, et al. High efficiency gene transfer to human hematopoletic SCID-repopulating cells under serum-free conditions. Blood. 1998;92:3163-3171.
32. Malech HL, Maples PB, Whiting-Theobald N, et al. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc Natl Acad Sci U S A. 1997;94:12,133-12,138.
33. Orlic D, Girard LJ, Anderson SM, Cline AP, Bodine DM. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency at retrovirus transduction. Proc Natl Acad Sci U S A. 1996;93:11,097-11,102.
34. Moritz T, Mackay W, Glassner BJ, Williams DA, Samson L. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic calls from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res. 1995;55: 2608-2614.
35. Blaese RM, Culver KW, Miller AD, et al. T lymphocyte-directed gene therapy lor ADA-SCID: Initial trial results after 4 years. Science. 1995; 270:475-480.
36. Bordignon C, Notrarangelo LD, Nobili N, et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science. 1995;270:470-475.
37. + cells in ADA-deficient SCID neonates. Nat Med. 1998;4:775-780.
38. Bunting KD, Flynn KJ, Riberdy JM, Doherty PC, Sorrentino BP. Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency. Proc Natl Acad Sci U S A. 1999;96:232-237.